![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Ovarian Neoplasms |
|
Free Subscription
|
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist
Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated
liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
Br J Cancer. 2026 Apr 8. doi: 10.1038/s41416-026-03430.
PubMed
Abstract available
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and
anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer. 2026 Apr 7. doi: 10.1038/s41416-026-03416.
PubMed
Abstract available
Value of whole-body diffusion-weighted MRI for the prediction of surgical and
clinical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Br J Cancer. 2026 Apr 4. doi: 10.1038/s41416-026-03383.
PubMed
Abstract available
GLT8D2-mediated PD-L1 N-glycosylation promotes tumor immune evasion in ovarian
cancer peritoneal metastasis.
Cancer Lett. 2026 Apr 3:218478. doi: 10.1016/j.canlet.2026.218478.
PubMed
Abstract available
Evaluating alternative protocols for preventing cisplatin-induced acute kidney
injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer.
Gynecol Oncol. 2026;208:85-90.
PubMed
Abstract available
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere
Proliferation and Metastasis.
Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70467.
PubMed
Abstract available
Thank you for your interest in scientific medicine.